Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.115 USD | +0.45% | +17.74% | -40.48% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.91M | Capitalization | 74.21M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-0.92
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Bionano Genomics, Inc.
1 day | -3.48% | ||
1 week | +12.98% | ||
Current month | +25.69% | ||
1 month | +29.75% | ||
3 months | -11.20% | ||
6 months | -15.27% | ||
Current year | -41.27% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +10.70% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.125 | +1.35% | 381 599 |
24-05-16 | 1.11 | -3.48% | 1,468,694 |
24-05-15 | 1.15 | +3.60% | 2,412,188 |
24-05-14 | 1.11 | +7.77% | 2,138,660 |
24-05-13 | 1.03 | +7.80% | 1,390,951 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.27% | 74.21M | |
+12.50% | 228B | |
+14.52% | 196B | |
+17.51% | 141B | |
+28.96% | 110B | |
+2.02% | 65.88B | |
+18.16% | 54.3B | |
+7.63% | 52.39B | |
+10.95% | 45.22B | |
+5.10% | 37.12B |
- Stock Market
- Equities
- BNGO Stock